CVKD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cadrenal Therapeutics Inc (CVKD) is not a good buy for a beginner, long-term investor at this time. The stock exhibits bearish technical indicators, lacks positive news or catalysts, and has weak financial performance. Additionally, there are no proprietary trading signals or significant trading trends to suggest a strong entry point.
The stock shows bearish technical indicators. The MACD is negative and expanding downward (-0.114), the RSI is neutral at 29.375, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 7.011, S2: 6.652), indicating further downside risk.
NULL. No recent news, trading trends, or congress trading data to suggest positive momentum.
Bearish technical indicators, declining EPS (-39.91% YoY), and no recent positive news or trading signals.
The company's financials for Q3 2025 show no revenue growth (0% YoY), a net income loss of -$2,685,705 (though improved by 11.54% YoY), and a significant EPS decline of -39.91% YoY to -1.31. Gross margin remains at 0%.
No analyst rating or price target changes available.
